A new method of wound treatment: Targeted therapy of skin wounds with reactive oxygen species-responsive nanoparticles containing SDF-1α

International Journal of Nanomedicine

Volumn 10, Issue , 2015, Pages 6571-6585

  Tang, Tao ^a   Jiang, Hao ^a   Yu, Yuan ^a   He, Fang ^a   Ji, Shi Zhao ^a   Liu, Ying Ying ^a   Wang, Zhong Shan ^a   Xiao, Shi Chu ^a   Tang, Cui ^b   Wang, Guang Yi ^a   Xia, Zhao Fan ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Bone marrow mesenchymal stem cells; Reactive oxygen species; Stromal cell derived factor 1 ; Wound healing

Indexed keywords

NANOPARTICLE; POLY (1,4 PHENYLENEACETONE DIMETHYLENE THIOKETAL); POLYMER; REACTIVE OXYGEN METABOLITE; STROMAL CELL DERIVED FACTOR 1ALPHA; UNCLASSIFIED DRUG; DRUG CARRIER; STROMAL CELL DERIVED FACTOR 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CELL PROLIFERATION; CHEMOTAXIS; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG RELEASE; EVAPORATION; IN VITRO STUDY; IN VIVO STUDY; MALE; MOLECULAR WEIGHT; MOUSE; NANOBIOTECHNOLOGY; NANOENCAPSULATION; NANOFABRICATION; NONHUMAN; PHYSICAL CHEMISTRY; PROTEIN STABILITY; SKIN INJURY; VASCULARIZATION; WOUND CARE; WOUND HEALING; ANGIOGENESIS; ANIMAL; CHEMISTRY; DRUG EFFECTS; INJURIES; METABOLISM; NANOMEDICINE; PROCEDURES; SKIN;

ANIMALS; CHEMOKINE CXCL12; DRUG CARRIERS; DRUG LIBERATION; MALE; MICE; NANOMEDICINE; NANOPARTICLES; NEOVASCULARIZATION, PHYSIOLOGIC; POLYMERS; REACTIVE OXYGEN SPECIES; SKIN; WOUND HEALING;

EID: 84944885197     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S88384     Document Type: Article

References (34)

1. Balaji S, Keswani SG, Crombleholme TM. The role of mesenchymal stem cells in the regenerative wound healing phenotype. Adv Wound Care (New Rochelle). 2012;1(4):159-165.
2. Singer NG, Caplan AI. Mesenchymal stem cells: mechanisms of inflammation. Annu Rev Pathol. 2011;6:457-478.
3. Xi J, Yan X, Zhou J, Yue W, Pei X. Mesenchymal stem cells in tissue repairing and regeneration: progress and future. Burn Trauma. 2013;1(1):13-20.
4. Kim S, Chaudhry A, Lee I, Frank JA. Effects of long-term hypoxia and pro-survival cocktail in bone marrow-derived stromal cell survival. Stem Cells Dev. 2014;23(5):530-540.
5. Thieme S, Ryser M, Gentsch M, et al. Stromal cell-derived factor-1alpha-directed chemoattraction of transiently CXCR4-overexpressing bone marrow stromal cells into functionalized three-dimensional biomimetic scaffolds. Tissue Eng Part C Methods. 2009;15(4):687-696.
6. Corcione A, Ottonello L, Tortolina G, et al. Stromal cell-derived factor-1 as a chemoattractant for follicular center lymphoma B cells. J Natl Cancer Inst. 2000;92(8):628-635.
7. Togel F, Isaac J, Hu Z, Weiss K, Westenfelder C. Renal SDF-1 signals mobilization and homing of CXCR4-positive cells to the kidney after ischemic injury. Kidney Int. 2005;67(5):1772-1784.
8. Lee BC, Hsu HC, Tseng WY, et al. Cell therapy generates a favourable chemokine gradient for stem cell recruitment into the infarcted heart in rabbits. Eur J Heart Fail. 2009;11(3):238-245.
9. Shen H, Cheng T, Olszak I, et al. CXCR-4 desensitization is associated with tissue localization of hemopoietic progenitor cells. J Immunol. 2001;166(8):5027-5033.
10. Hattori K, Heissig B, Tashiro K, et al. Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells. Blood. 2001;97(11):3354-3360.
11. Kommareddy S, Amiji M. Biodistribution and pharmacokinetic analysis of long-circulating thiolated gelatin nanoparticles following systemic administration in breast cancer-bearing mice. J Pharm Sci. 2007;96(2):397-407.
12. Delie F, Blanco-Prieto MJ. Polymeric particulates to improve oral bioavailability of peptide drugs. Molecules. 2005;10(1):65-80.
13. Okuda T, Kawakami S, Akimoto N, Niidome T, Yamashita F, Hashida M. PEGylated lysine dendrimers for tumor-selective targeting after intravenous injection in tumor-bearing mice. J Control Release. 2006;116(3):330-336.
14. Bryan N, Ahswin H, Smart N, Bayon Y, Wohlert S, Hunt JA. Reactive oxygen species (ROS) - a family of fate deciding molecules pivotal in constructive inflammation and wound healing. Eur Cell Mater. 2012;24:249-265.
15. Napoli A, Valentini M, Tirelli N, Muller M, Hubbell JA. Oxidation-responsive polymeric vesicles. Nat Mater. 2004;3(3):183-189.
16. Wilson DS, Dalmasso G, Wang L, Sitaraman SV, Merlin D, Murthy N. Orally delivered thioketal nanoparticles loaded with TNF-alpha-siRNA target inflammation and inhibit gene expression in the intestines. Nat Mater. 2010;9(11):923-928.
17. Samy RP, Thwin MM, Chow VT, Bow H, Gopalakrishnakone P. Evaluation of antibacterial activity of proteins and peptides using a specific animal model for wound healing. Methods Mol Biol. 2011;716:245-265.
18. Gasper MM, Blanco D, Cruz ME, Alonso MJ. Formulation of L-asparaginase-loaded poly(lactide-co-glycolide) nanoparticles: influence of polymer properties on enzyme loading, activity and in vitro release. J Control Release. 1998;52(1-2):53-62.
19. Murata N, Takashima Y, Toyoshima K, Yamamoto M, Okada H. Anti-tumor effects of anti-VEGF siRNA encapsulated with PLGA microspheres in mice. J Control Release. 2008;126(3):246-254.
20. Hiasa K, Ishibashi M, Ohtani K, et al. Gene transfer of stromal cell-derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization. Circulation. 2004;109(20):2454-2461.
21. Tan Y, Shao H, Eton D, et al. Stromal cell-derived factor-1 enhances pro-angiogenic effect of granulocyte-colony stimulating factor. Cardiovasc Res. 2007;73(4):823-832.
22. Heathcote EJ, Shiffman ML, Cooksley WG, et al. Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis. N Engl J Med. 2000;343(23):1673-1680.
23. Misra P, Lebeche D, Ly H, et al. Quantitation of CXCR4 expression in myocardial infarction using 99mTc-labeled SDF-1alpha. J Nucl Med. 2008;49(6):963-969.
24. Ye M, Kim S, Park K. Issues in long-term protein delivery using biodegradable microparticles. J Control Release. 2010;146(2):241-260.
25. Rasik AM, Shukla A. Antioxidant status in delayed healing type of wounds. Int J Exp Pathol. 2000;81(4):257-263.
26. Jin T, Zhu J, Wu F, Yuan W, Geng LL, Zhu H. Preparing polymer-based sustained-release systems without exposing proteins to water-oil or water-air interfaces and cross-linking reagents. J Control Release. 2008;128(1):50-59.
27. Yuan W, Geng Y, Wu F, et al. Preparation of polysaccharide glassy microparticles with stabilization of proteins. Int J Pharm. 2009;366(1-2):154-159.
28. Liu D, Mori A, Huang L. Role of liposome size and RES blockade in controlling biodistribution and tumor uptake of GM1-containing liposomes. Biochim Biophys Acta. 1992;1104(1):95-101.
29. Sonavane G, Tomoda K, Makino K. Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size. Colloids Surf B Biointerfaces. 2008;66(2):274-280.
30. Gaur U, Sahoo SK, De TK, Ghosh PC, Maitra A, Ghosh PK. Biodistribution of fluoresceinated dextran using novel nanoparticles evading reticuloendothelial system. Int J Pharm. 2000;202(1-2):1-10.
31. Banerjee T, Mitra S, Kumar Singh A, Kumar Sharma R, Maitra A. Preparation, characterization and biodistribution of ultrafine chitosan nanoparticles. Int J Pharm. 2002;243(1-2):93-105.
32. Ruan G, Feng SS, Li QT. Effects of material hydrophobicity on physical properties of polymeric microspheres formed by double emulsion process. J Control Release. 2002;84(3):151-160.
33. Ribeiro J, Pereira T, Amorim I, et al. Cell therapy with human MSCs isolated from the umbilical cord Wharton jelly associated to a PVA membrane in the treatment of chronic skin wounds. Int J Med Sci. 2014;11(10):979-987.
34. Garg RK, Rennert RC, Duscher D, et al. Capillary force seeding of hydrogels for adipose-derived stem cell delivery in wounds. Stem Cells Transl Med. 2014;3(9):1079-1089.